Uncovering overlooked growth stocks for the patient investor | High quality analysis of the hidden market-beating companies
| Platform |  | Pricing | Freemium | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 56 | Founded | a year ago | Last Issue | 8 days ago |
| Active | |||||
Read this Newsletter
bullseyeinvesting.substack.comLatest Issues
Zeta Global ($ZETA): The Beat and Raise Machine
On August 4th, Zeta Global reported a quarter where they beat earnings and raised guidance. This is not unusual for the company; they have done this 20 straight quarters. In fact, Zeta has recorded a beat-and-raise every single quarter sinc...
Understanding Valuation Multiples
Value investors who follow in the philosophy of Buffett and Graham are taught to use the PE ratio as a guide as to whether a stock is undervalued or overvalued. The core principle is simple; how much more would you pay than a company earns...
Pro-Dex ($PDEX): A Small Medical Device Manufacturer with High Upside
If you have any feedback on Bullseye Research, I would love to hear it. I hope you’ve enjoyed reading thus far, and I would appreciate if you would fill out this quick, three-question survey:
Start Survey
There are two key d...
Q2 Earnings Updates on Alphabet, GE Vernova, and ServiceNow
The first major earnings week of Q2 has been quite tumultuous, so I believe it’s time to recap what I’ve been seeing. AI investment, growth that the market doesn’t believe, and data centers continuing to boom have been key themes of this ea...
Long-Term Investing in a Short-Term World
Search for the stock chart of any successful, long-running company that you can think of. Check that stock’s past one-year of returns. Perhaps it had a strong year and is up 25% or more. Maybe it’s had a rough stretch, and is down 10%.
Th...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Bullseye Research.
| Subscribers | Engagement | 75 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
I research and invest in amazing companies at great prices | Invest with confidence | GARP investing | Inquiries: [email protected] | My track record \ud83d\udc47
Frequently Asked Questions
How can I access the email archive for Bullseye Research?
You can find recent issues that have been published by Bullseye Research on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Bullseye Research have?
To see how many people subscribe to Bullseye Research, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Bullseye Research?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Bullseye Research as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Bullseye Research?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Bullseye Research using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Bullseye Research?
Scroll up to where it says Related Newsletters to see other publications like Bullseye Research. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Bullseye Research?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.